Pathways Study Genotype Data, Alliance A011502 Sec
New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park
Stay updated with breaking news from Pathways Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New insights on improving clinical outcomes and quality of life among breast cancer patients highlight the slate of new research presentations Roswell Park
A new study supports accumulating evidence that HER2-low breast cancer is a distinct biologic entity from HER2-negative breast cancer, according to researchers. A new study supports accumulating evidence that HER2-low breast cancer is a distinct biologic entity from HER2-negative breast cancer.
A Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer survivors: Is it safe to drink alcohol?
A multidisciplinary team of researchers from Roswell Park Comprehensive Cancer Center and Kaiser Permanente Northern California have identified the first pharmacogenomic marker for anthracyclines and HER2-targeting drugs, two commonly used breast cancer chemotherapies.
Newly discovered genetic marker identifies patients who will best respond to specific chemotherapies.